tag:blogger.com,1999:blog-2678610943099684074.post7478002960859040538..comments2024-03-16T15:28:35.543+01:00Comments on Médicalement Geek: Dragi Webdo n°107: SUSTAIN-6 (semaglutide vs placebo), statines, Bacloville, vaccins HPV/Zona, cancer prostate, maltraitance (et Pokemon)Dr Agibushttp://www.blogger.com/profile/03875451396717083330noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-2678610943099684074.post-46475630623668762452018-10-15T18:13:29.224+02:002018-10-15T18:13:29.224+02:00Semaglutide is an agonist of glucagon-like peptide...Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin. On Oct 18, 2017, Novo Nordisk received positive 16-0 vote from FDA Advisory Committee in favor of approval for Semaglutide. <a href="https://www.bocsci.com/semaglutide-cas-910463-68-2-item-7194.html" rel="nofollow">Semaglutide</a><br />Anonymoushttps://www.blogger.com/profile/12128271861530734257noreply@blogger.com